TORONTO (AP) _ Aptose Biosciences Inc. (APTO) on Tuesday reported a loss of $7.7 million in its fourth quarter.
The Toronto-based company said it had a loss of 13 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.
For the year, the company reported that its loss narrowed to $26.3 million, or 52 cents per share.
Aptose Biosciences shares have increased 25% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $7.08, more than quadrupling in the last 12 months.